GATC Health invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference

IRVINE, Calif., June 6, 2022—GATC Health, a science and technology company revolutionizing drug discovery and disease prediction using artificial intelligence and advanced multiomics, is pleased to announce that it has been invited to present at the Emerging Growth Conference on Wednesday June 8, 2022.

The Emerging Growth Conference is a live, interactive online event that will give existing shareholders and the investment community the opportunity to interact with the Company’s Chief Operation Officer, Tyrone Lam and Chief Marketing Officer, Preetaman Wadhwa, in real time.

Tyrone and Preetaman will provide a detailed presentation regarding the company, its products and market opportunity, and may subsequently open the floor for questions. Please ask your questions during the event and Tyrone and Preetaman will do their best to get through as many of them as possible.

GATC Health will be presenting at 2:00 – 2:30 PM Eastern time.

Please register here to ensure you are able to attend the conference and receive any updates that are released.

https://goto.webcasts.com/starthere.jsp?ei=1544049&tp_key=fa993d31c5&sti=gatc 

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and we will also release a link to that after the event.

To contact GATC Health: info@gatchealth.com • 833-333-GATC (4282)

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and th overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

About GATC HealthGATC Health Corp is a science and technology company using whole genome analysis and multiomics-based artificial intelligence to revolutionize disease detection and drug discovery. The company’s patented AI platform reduces risk, time and costs for life science companies by digitally reproducing the human body to find non-obvious answers to biology’s most complex questions. GATC Health is accelerating healthcare’s transition to predictive, individualized medicine.Disclaimer

The information set forth herein is presented for informational purposes only and should not be deemed an offer to sell securities.  This announcement contains information which the Company believes to be correct, including certain financial information and projections, but the Company does not guarantee as to the accuracy or completeness of such information.  The Company reserves the right to modify or amend the information contained herein.